enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. AstraZeneca's Imfinzi gets FDA priority review for type of ...

   www.aol.com/news/astrazenecas-imfinzi-gets-fda...

   AstraZeneca's application was based on positive late-stage data that showed the drug improved overall survival and progression-free survival in patients with a type of lung cancer, whose disease ...

3. AstraZeneca's Investigational Cancer Drug Disappoints In Late ...

   www.aol.com/astrazenecas-investigational-cancer...

   Monday, AstraZeneca Plc (NASDAQ:AZN) shared detailed results from the TROPION-Lung01 Phase 3 of datopotamab deruxtecan (Dato-DXd) compared to docetaxel, the current standard of care chemotherapy ...

4. AstraZeneca's Imfinzi fails in late-stage trial to treat ...

   www.aol.com/news/astrazenecas-imfinzi-fails...

   The trial, known as ADJUVANT BR.31 Phase III, sought to evaluate Imfinzi in the adjuvant treatment of 1,415 patients with an early stage of non-small-cell lung cancer following complete tumour ...

5. AstraZeneca stock drops after lung cancer drug trial setback

   www.aol.com/news/astrazeneca-shares-drop-lung...

   (Reuters) -London-listed AstraZeneca shares fell more than 5% on Tuesday after results from the company's lung cancer trials showed that its experimental precision drug did not significantly ...

6. Saracatinib - Wikipedia

   en.wikipedia.org/wiki/Saracatinib

   Saracatinib (AZD-0530) is an experimental drug being developed by AstraZeneca. It acts as a dual kinase inhibitor, with selective actions as a Src inhibitor and a Bcr-Abl tyrosine-kinase inhibitor. [1] [2]

7. AstraZeneca says lung cancer drug trial shows no significant ...

   www.aol.com/news/astrazeneca-says-lung-cancer...

   The trial compared the two treatments -- AstraZeneca's drug and chemotherapy -- of patients whose non-small cell lung cancer had returned after one or two prior treatment attempts.

8. Savolitinib - Wikipedia

   en.wikipedia.org/wiki/Savolitinib

   It is being investigated for the treatment of cancer by AstraZeneca. [1] It is in phase II clinical trials for adenocarcinoma, non-small cell lung cancer, and renal cell carcinoma. [2] It has been given conditional approval for these indication in China. [3]

9. AstraZeneca's Imfinzi improves survival in late-stage lung ...

   www.aol.com/news/astrazenecas-imfinzi-shows...

   (Reuters) -AstraZeneca said on Friday its blockbuster cancer drug Imfinzi helped improve survival in patients in the early stages of an aggressive type of lung cancer, making it the first such ...